This comprehensive review delves into the AcrAB-TolC tripartite efflux pump, a major contributor to multidrug resistance in Gram-negative bacteria like Escherichia coli.
This article provides a comprehensive analysis of pharmacokinetic/pharmacodynamic (PK/PD) target attainment strategies for novel antibiotics targeting resistant Gram-positive pathogens.
This article provides a detailed framework for researchers and drug development professionals implementing Area Under the Curve (AUC)-guided vancomycin dosing.
This article provides a comprehensive blueprint for designing and implementing a clinical trial protocol for the AP-SA02 phage cocktail, a novel therapeutic targeting drug-resistant Staphylococcus aureus.
This article provides a comprehensive framework for antimicrobial resistance (AMR) surveillance targeting the WHO's priority pathogens list.
This article provides a comprehensive analysis for researchers and drug development professionals on the emerging paradigm of AI-designed antibiotic compounds versus traditional natural product-derived antibiotics.
This article provides a comprehensive analysis for researchers and drug development professionals on the use of artificial intelligence to discover new antibiotic candidates targeting the critical pathogen Acinetobacter baumannii.
This article provides a comprehensive exploration of AI-integrated Physiologically Based Pharmacokinetic (PBPK) models for predicting antibiotic behavior.
This article provides a comprehensive overview for researchers, scientists, and drug development professionals on the application of artificial intelligence (AI) and machine learning (ML) in predicting novel antimicrobial compounds.
This article provides a comprehensive analysis of the Absorption, Distribution, Metabolism, and Excretion (ADME) profiles of modern long-acting lipoglycopeptide antibiotics, such as dalbavancin and oritavancin.